NivolumabFulminant type 1 diabetes mellitus: case report

被引：0
作者：
机构：
来源：
Reactions Weekly | 2016年 / 1631卷 / 1期
关键词：
D O I：
10.1007/s40278-016-23918-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：140 / 140
相关论文
共 50 条
[31]   Interferon-αType 1 diabetes mellitus: case report [J].
Reactions Weekly, 2018, 1704 (1) :203-203
[32]   A case report of atypical presentation of type 1 diabetes mellitus [J].
Rogers, M. ;
Long, A. .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 367 :S118-S119
[33]   AntineoplasticsLack of efficacy and type 1 diabetes mellitus: case report [J].
Reactions Weekly, 2025, 2060 (1) :42-42
[34]   TozinameranGraves' disease and type 1 diabetes mellitus: case report [J].
Reactions Weekly, 2022, 1894 (1) :301-301
[35]   PembrolizumabFulminant type-1 diabetes mellitus: case report [J].
Reactions Weekly, 2019, 1761 (1) :297-297
[36]   ElasomeranFulminant type-1 diabetes mellitus: case report [J].
Reactions Weekly, 2025, 2060 (1) :142-142
[37]   Diagnosis of type 1 diabetes mellitus in adulthood - a case report [J].
Saleh, Ashraf .
AUSTRALIAN FAMILY PHYSICIAN, 2015, 44 (04) :233-235
[38]   PembrolizumabAutoimmune diabetes mellitus type 1 and colitis: case report [J].
Reactions Weekly, 2019, 1743 (1) :178-178
[39]   AvelumabFulminant type-1 diabetes mellitus: case report [J].
Reactions Weekly, 2019, 1772 (1) :67-67
[40]   PembrolizumabFulminant type 1 diabetes mellitus and ketoacidosis: case report [J].
Reactions Weekly, 2023, 1957 (1) :448-448
12345